Oral cyclophosphamide improves pulmonary function in scleroderma patients with fibrosing alveolitis: experience in one centre.

Clinical Rheumatology
Lorenzo BerettaRaffaella Scorza

Abstract

Lung involvement constitutes nowadays the major cause of morbidity and mortality in scleroderma patients. Pulmonary fibrosis in systemic sclerosis (SSc) is thought to be the consequence of interstitial inflammation. Early diagnosis and treatment of active alveolitis is essential to prevent the deterioration of pulmonary function, improving outcome in SSc patients. The aim of the study was to investigate the effect of 1-year treatment with oral cyclophosphamide (CYC) on the evolution of interstitial lung disease in scleroderma patients with a diagnosis of active alveolitis. An open-label one-arm monocenteric study was conducted on 33 scleroderma patients with active alveolitis--defined as the presence of areas of 'ground-glass attenuation' on high-resolution computed tomography and a recent deterioration in lung function-treated with oral CYC 2 mg kg-1 day-1 for 1 year and medium-low dose steroids (prednisone 25 mg for 3 months and then tapered to 5 mg/day). Results showed that diffusing capacity for carbon monoxide (DLco) values remained stable after 6 months of treatment and significantly increased after 12 months (2.06+/-1.38, 2.21+/-1.62 and 2.39+/-1.64 mmol/min/kPa, at baseline/6/12 months, respectively; p<0.001 12th month ...Continue Reading

References

Nov 1, 1991·Annals of the Rheumatic Diseases·R M Silver
Sep 1, 1991·The American Review of Respiratory Disease·N K HarrisonM Turner-Warwick
Apr 11, 1991·Arthritis and Rheumatism·R D AltmanB A Michel
May 1, 1990·The American Journal of Medicine·R M SilverS I Schabel
Aug 1, 1994·American Journal of Respiratory and Critical Care Medicine·A U WellsR M Du Bois
May 1, 1994·Arthritis and Rheumatism·A AkessonF A Wollheim
May 1, 1998·American Journal of Respiratory and Critical Care Medicine·S E GayF J Martinez
Nov 18, 2000·Arthritis and Rheumatism·V D Steen, T A Medsger
Jun 19, 2002·American Journal of Respiratory and Critical Care Medicine·Demosthenes BourosRoland M du Bois

❮ Previous
Next ❯

Citations

Nov 5, 2013·Rheumatology·Susanna CappelliMarco Matucci-Cerinic
Dec 19, 2006·Seminars in Cutaneous Medicine and Surgery·Melissa I Costner, Renee H Grau
Oct 4, 2007·Annals of the New York Academy of Sciences·Alice BéreznéLuc Mouthon
Dec 9, 2008·La Presse médicale·Guillaume BussoneLuc Mouthon
May 18, 2018·European Respiratory Review : an Official Journal of the European Respiratory Society·Melissa CaronRussell Steele
Dec 7, 2010·Rheumatology International·Gerald TrangMarie Hudson
Jun 22, 2011·Rheumatology International·Hadi PoormoghimNeda Toofaninjed
Apr 25, 2018·The Journal of Dermatology·Yoshihide AsanoHironobu Ihn
May 7, 2011·Arthritis and Rheumatism·Michael D RothUNKNOWN Scleroderma Lung Study Research Group
Mar 3, 2020·The Lancet. Respiratory Medicine·Apostolos PerelasKristin B Highland

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.